Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02473419 · ClinicalTrials.gov registry record
Neurobiological Basis of Response to Vayarin in Adults With ADHD: an fMRI Study of Brain Activation Pre and Post Treatment
A clinical trial, sponsored by Icahn School of Medicine at Mount Sinai.
- Completed
- Registry status
- 107
- Enrollment target
NCT02473419: Completed study, sponsored by Icahn School of Medicine at Mount Sinai.
NCT02473419 is a clinical trial that has completed, run by Icahn School of Medicine at Mount Sinai. The registered enrollment target is 107 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02473419 has completed, sponsored by Icahn School of Medicine at Mount Sinai.
- COMPLETED
- Registry status
- 107 participants
- Enrollment target
Study Summary
The objective of this research is to use functional magnetic resonance imaging (fMRI) with a neuropsychological task to test the prefrontal mechanism of action of the medical food Vayarin.
Primary Outcome
Change in the emotional go/no-go task performed in the fMRI scanner at 16 weeks as compared to baseline
Interventions
- DRUG Placebo
- DRUG Vayarin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 107 participants |
| Start Date | 2015-05 |
| Est. Completion | 2017-03-02 |
What the finished NCT02473419 record still lists
NCT02473419 is an observational study that tracks outcomes without assigning an intervention. The registered 107 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT02473419 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02473419 about?
NCT02473419 is a clinical study titled "Neurobiological Basis of Response to Vayarin in Adults With ADHD: an fMRI Study of Brain Activation Pre and Post Treatment". The objective of this research is to use functional magnetic resonance imaging (fMRI) with a neuropsychological task to test the prefrontal mechanism of action of the medical food Vayarin.
What is the current status of trial NCT02473419?
This trial is currently completed. The enrollment target is 107 participants. The study started on 2015-05. Estimated completion is 2017-03-02.
What interventions are being tested in trial NCT02473419?
The interventions under investigation include: Placebo (DRUG), Vayarin (DRUG).
Who is sponsoring clinical trial NCT02473419?
This trial is sponsored by Icahn School of Medicine at Mount Sinai, which has 708 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05491668 · 107 participants
Physiological Assessment of Severe Coronary Stenosis for Informing Planned PCI
- NCT06041594 · 107 participants · NA
Treating Pulmonary Embolism With Laguna Thrombectomy System (TRUST)
- NCT06081426 · 107 participants · NA
Examining Neurobiological Mechanisms Underlying the Therapeutic Effect of the Ketogenic Diet in Bipolar Disorder (BD)
- NCT06527599 · 107 participants · NA
Screening in Trauma for Opioid Misuse Prevention - an Adaptive Intervention
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia